Veterinary Infusion Pumps Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Veterinary Infusion Pumps Market is projected to expand from USD 312.45 Million in 2025 to USD 475.25 Million by 2031, reflecting a compound annual growth rate of 7.24%. These medical devices are essential for delivering precise volumes of fluids, medications, and nutrients to animals, with demand largely fueled by the growing global pet population and rising spending on animal healthcare. This upward trajectory is further bolstered by the increasing incidence of chronic animal diseases requiring sustained fluid therapy, alongside the trend of pet humanization that drives owners to seek superior medical treatments. According to the American Pet Products Association, total U.S. pet industry expenditures hit $152 billion in 2024, highlighting the substantial financial commitment owners are willing to make for high-standard care and advanced fluid management technologies.

Despite these favorable conditions, the market confronts a notable obstacle regarding the substantial acquisition and maintenance expenses linked to modern infusion systems. Small-scale veterinary clinics frequently encounter difficulties meeting these capital requirements, which restricts the broad adoption of such advanced technology in developing areas or practices operating with limited budgets. Consequently, while the demand for sophisticated care grows, financial constraints within smaller facilities continue to hinder the universal implementation of these critical medical devices.

Market Drivers

The escalating incidence of chronic and age-related veterinary conditions serves as a major driver for the broad implementation of infusion pumps within animal healthcare. As companion animals enjoy longer lifespans, they become more prone to complex ailments such as renal failure, cancer, and diabetes, which often require exact fluid regulation and prolonged medication administration. Obesity further aggravates these health dangers, resulting in increased surgical procedures and critical care needs where automated infusion systems are vital for ensuring patient safety. According to the Association for Pet Obesity Prevention's '2024 Pet Obesity & Nutrition Opinion Survey' released in April 2025, 35% of dog owners and 33% of cat owners reported their pets were overweight or obese, creating a direct link between weight-related health issues and the demand for sophisticated therapeutic equipment.

Furthermore, the broadening of pet insurance coverage and healthcare spending is pivotal in rendering these advanced treatments financially feasible for a wider audience. With the security of insurance, pet owners are more likely to pursue expensive interventions, such as continuous infusion therapies and post-operative care, which were previously deemed too costly. This shift is reflected in the insurance sector's strong performance; the North American Pet Health Insurance Association's 'State of the Industry Report 2025' noted that the total number of insured pets in North America hit 7.03 million by the end of 2024. Additionally, the Association of British Insurers reported in 2025 that total pet insurance payouts reached a record £1.23 billion for the preceding year, empowering veterinary facilities to purchase high-quality infusion pumps to satisfy the elevated care standards expected by insured clients.

Market Challenges

The substantial expenses involved in acquiring and maintaining modern veterinary infusion systems represent a significant hurdle to market growth. Although advanced infusion pumps provide superior fluid delivery and enhanced patient safety, they necessitate a considerable initial capital outlay that is often difficult for smaller or independent veterinary clinics to justify. In addition to the purchase price, these devices require ongoing funding for specialized consumables, routine calibration, and technical servicing, further burdening the operational budgets of veterinary practices. As a result, many facilities with limited financial resources are forced to depend on manual fluid administration techniques or outdated equipment, which effectively impedes the widespread integration of advanced technology.

This economic strain is underscored by recent industry financial data illustrating the fiscal difficulties practices face. According to the American Veterinary Medical Association, the average gross revenue per full-time equivalent veterinarian in 2024 was approximately $554,982, a figure indicating a decline when adjusted for inflation compared to previous benchmarks. This reduction in real purchasing power restricts the discretionary funds available for practice enhancements. Consequently, when veterinary clinics encounter stagnating revenue, they are compelled to delay or forego investments in expensive medical devices such as infusion pumps, which directly hampers the overall expansion of the global market.

Market Trends

The incorporation of wireless connectivity and IoT capabilities is transforming the Global Veterinary Infusion Pumps Market by meeting the critical demand for operational efficiency in veterinary practices. Clinics are increasingly implementing smart infusion systems that automatically sync treatment data with electronic medical records, thereby minimizing manual entry errors and allowing staff to focus on patient care. These connected devices enable remote monitoring of fluid delivery, which ensures safety while streamlining workflows in understaffed facilities. This movement toward digital optimization is supported by industry feedback; according to the 'Top Veterinary Industry Trends to Watch in 2024 and Beyond' report by Covetrus in July 2024, over 80% of veterinary professionals stated they are actively prioritizing the optimization of practice technology to reduce administrative workloads.

Concurrently, the growth of home-based veterinary infusion therapy is becoming a significant trend, driven by the escalating costs of advanced inpatient care. Veterinary facilities are utilizing compact, ambulatory infusion pumps that allow pet owners to administer long-term treatments, such as chemotherapy or pain management, within the comfort of their homes. This transition facilitates earlier patient discharge, effectively bridging the gap between required medical protocols and financial feasibility. This trend primarily addresses economic pressures on pet owners; according to the 'Veterinary Specialty Care Study' by Synchrony in October 2024, 72% of pet parents expressed being very or extremely concerned regarding the financial impact of specialty veterinary care, stimulating market demand for more affordable outpatient delivery solutions.

Key Players Profiled in the Veterinary Infusion Pumps Market

• B. Braun Melsungen AG
• HESKA Corporation
• Burtons Medical Equipment Ltd.
• Digicare Biomedical Technology, Inc.
• Dre Veterinary, Inc.
• Grady Medical Systems, Inc.
• Jorgen Kruuse A/S
• Jorgensen Laboratories
• Leading Edge Veterinary Equipment
• Q Core Medical Ltd.

Report Scope

In this report, the Global Veterinary Infusion Pumps Market has been segmented into the following categories:

Veterinary Infusion Pumps Market, by Type:

• Large Volume Infusion Pumps
• Syringe Infusion Pumps

Veterinary Infusion Pumps Market, by End User:

• Private Hospitals
• Private Clinics
• Teaching Hospitals

Veterinary Infusion Pumps Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Infusion Pumps Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.